Osivax Revenue

Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 51-100 Employees

Osivax revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$176,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$31,500,000

Key Contacts at Osivax

Jessika Tourneur

Program Director

Florence Nicolas

Director Of Development And Co-Funder

Company overview

Headquarters	70, Rue Saint-Jean-de-Dieu, Lyon, Auvergne-Rhône-Alpes 69007, FR
Phone number	+3309703013
Website	osivax.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Infectious Diseases, Universal, Immunology, Immuno-Oncology, Influenza, Antigens, Vaccine, Covid, Cd8 T-Cell, Cellular Immune Response
Founded	2017
Employees	51-100
Socials

Osivax Email Formats

Osivax uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@osivax.com), used 65.1% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@osivax.com	65.1%
{first name}{last name}	johndoe@osivax.com	32.6%
{first initial}{second initial}{last name}	jodoe@osivax.com	2.3%

About Osivax

Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Head

Employees by Department

Osivax has 30 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Osivax's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2024-01-05	9	$1,500,000
2025-04-04	5	$10,500,000
2025-09-26	9	$19,500,000

Funding Insights

$31,500,000

Total funding amount

$19,500,000

Most recent funding amount

Number of funding rounds

Osivax Tech Stack

Discover the technologies and tools that power Osivax's digital infrastructure, from frameworks to analytics platforms.

Smart Slider 3

WordPress plugins

Site Kit

Analytics

Vimeo

Video players

lit-element

JavaScript libraries

DataTables

JavaScript libraries

jQuery UI

JavaScript libraries

Google Maps

Maps

Elementor

Page builders

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Frequently asked questions

Osivax is located in Lyon, Auvergne-Rhône-Alpes, FR.

You can reach Osivax at +3309703013.

Osivax generates an estimated annual revenue of $10,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Osivax has an estimated valuation of $32,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Osivax was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Osivax has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Osivax has raised a total of $31,500,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Osivax

Jessika Tourneur

Program Director

Florence Nicolas

Director Of Development And Co-Funder

4.8

40,000 users